Consistent with the in vivo results, the results in this model confirmed that overexpression of FOXP1 can attenuate the suppressive effect of NAT10 knockdown on tumor growth in vivo (Figure 3g–j), further emphasizing the crucial role of ac4C modification catalyzed by NAT10 in CCa tumor development. The gene discussed is FOXP1; the disease is neoplasm.